Doctors' profit-making schemes criticized

Beijing - The profit-making tendencies of healthcare providers who drive up medical costs have come under renewed criticism - this time by a member of China's top political advisory body, who cited the sale of heart stents at highly inflated prices at Chinese hospitals.

"Hospitals buy a made-in-China heart stent for 3,000 yuan ($456), but sell it to patients for 27,000 yuan. They buy an imported one for 6,000 yuan, but sell it for 38,000 yuan," said Dong Xieliang, a member of the National Committee of the Chinese People's Political Consultative Conference (CPPCC).

Inflated prices are not limited to complex medical devices and procedures. People also complain that treatments for minor illnesses cost more than necessary, according to earlier reports.